In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... significant growth over the past two years, and corporate profits are projected to rise by over 10% in 2025.

we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other stocks. Jim Cramer, the host of Mad Money, discussed the upcoming market and corporate activity to ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... as tariffs can adversely affect corporate profits and financial conditions. Lee’s pointing out of historical ...

We recently published an article titled Jim Cramer’s Game Plan: 15 Stocks in Focus. In this article, we are going to take a ...

Eli Lilly and Co.’s approval for Omvoh to treat moderate to severe Crohn’s disease in adults marks the Indianapolis company’s growing presence in the treatment of inflammatory bowel disease.

Daniel Ghinn explores the processes behind launching LillyPad, global pharmaceutical company Eli Lilly’s corporate blog, which has associated social media channels on YouTube, Facebook and Twitter.

U.S. pharmaceutical giant Eli Lilly is ... to utilize the company’s research and development (R&D) program Catalyze360. Catalyze360 consists of Eli Lilly's corporate venture capital (CVC ...

The shaving giant is looking for around 250,000 square feet of office space as it prepares to move out of, and then perhaps ...